Residual pharmaceutical products in sewage and other water environments have recently become a serious social problem in advanced countries. Among these pharmaceutical products, antibiotics have attracted special attention due to their serious impact on the ecosystem and connections to the emergence of drug-resistant bacteria. Our research intended to develop a new method to analyse the three antibiotics estimated to be released out of the body in large amounts in Japan; levofloxacin (LVFX), clarithromycin (CAM) and azithromycin (AZM), and survey the state of pollution in the sewerage. The concentrations of the water-phase antibiotics LVFX, CAM and AZM were measured in each process of activated sludge process in six wastewater treatment plants. Liquid chromatography tandem mass spectrometry (LC/MS/MS) was used to analyse solutions of the antibiotics after pretreatment with a solid phase extraction. The limits of quantification and the average recoveries for these antibiotics in the influent were 1.2 to 29 ng/L and 46 to 93%, respectively. In the influent, LVFX, CAM and AZM were detected at concentrations of 552, 647 and 260 ng/L, respectively, while their removal efficiencies were 42, 43 and 49%, respectively. Although the CAM and AZM concentrations decreased as the treatment progressed, it was shown that the LVFX concentration increased in activated sludge reactors in some cases. Despite differences in octanol-water partition coefficients among LVFX, CAM and AZM, their removal efficiency showed no major difference. This indicates that this removal phenomenon cannot be explained by simple adsorption by the activated sludge.
Skip Nav Destination
Article navigation
Abstract|
May 01 2006
Occurrence of levofloxacin, clarithromycin and azithromycin in wastewater treatment plant in Japan
M. Yasojima;
*Towa kagaku Corporation, 6-5 Funairi-machi Naka-ku, Hiroshima City, Hiroshima, 730-0841, Japan (E-mail: yaso@mail.towakagaku.co.jp)
E-mail: yaso@mail.towakagaku.co.jp
Search for other works by this author on:
N. Nakada;
N. Nakada
**Water Environment Research Group, Public Works Research Institute, 1-6 Minamihara, Tsukuba City, Ibaraki, 305-8516, Japan (E-mail: nakada55@pwri.go.jp; komori@pwri.go.jp; ysuzuki@pwri.go.jp)
Search for other works by this author on:
K. Komori;
K. Komori
**Water Environment Research Group, Public Works Research Institute, 1-6 Minamihara, Tsukuba City, Ibaraki, 305-8516, Japan (E-mail: nakada55@pwri.go.jp; komori@pwri.go.jp; ysuzuki@pwri.go.jp)
Search for other works by this author on:
Y. Suzuki;
Y. Suzuki
**Water Environment Research Group, Public Works Research Institute, 1-6 Minamihara, Tsukuba City, Ibaraki, 305-8516, Japan (E-mail: nakada55@pwri.go.jp; komori@pwri.go.jp; ysuzuki@pwri.go.jp)
Search for other works by this author on:
H. Tanaka
H. Tanaka
***Research Center for Environmental Quality Management, Kyoto University, 1-2 Yumihama, Otsu City, Shiga, 520-0811, Japan (E-mail: htanaka@biwa.eqc.kyoto-u.ac.jp)
Search for other works by this author on:
Water Sci Technol (2006) 53 (11): 227–233.
Citation
M. Yasojima, N. Nakada, K. Komori, Y. Suzuki, H. Tanaka; Occurrence of levofloxacin, clarithromycin and azithromycin in wastewater treatment plant in Japan. Water Sci Technol 1 May 2006; 53 (11): 227–233. doi: https://doi.org/10.2166/wst.2006.357
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Impact Factor 2.430
CiteScore 3.4 • Q2
13 days submission to first
decision
1,439,880 downloads in 2021
156
Views
48
Citations